Recent HCM News
- HUTCHMED Highlights Clinical Data to be Presented at the 2026 ASCO Annual Meeting • GlobeNewswire Inc. • 05/22/2026 12:00:00 AM
- HUTCHMED and Innovent Jointly Announce NMPA Approval for ELUNATE® (Fruquintinib) in Combination with TYVYT® (Sintilimab Injection) for the Treatment of Patients with Locally Advanced or Metastatic Renal Cell Carcinoma • GlobeNewswire Inc. • 05/21/2026 10:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/30/2026 10:04:35 AM
- Deutsche Bank ADR Virtual Investor Conference: Presentations Now Available for Online Viewing • GlobeNewswire Inc. • 04/29/2026 12:35:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 04/29/2026 10:21:20 AM
- HUTCHMED Announces NDA Acceptance in China with Priority Review Status and Breakthrough Designation for Sovleplenib for the Treatment of Warm Antibody Autoimmune Hemolytic Anemia • GlobeNewswire Inc. • 04/29/2026 10:00:00 AM
- International companies to host live webcasts at Deutsche Bank’s Depositary Receipts Virtual Investor Conference on April 28, 2026 • GlobeNewswire Inc. • 04/23/2026 12:35:00 PM
- HUTCHMED Highlights Data to be Presented at AACR Annual Meeting 2026 • GlobeNewswire Inc. • 04/09/2026 12:00:00 AM
- Form 3 - Initial statement of beneficial ownership of securities • Edgar (US Regulatory) • 03/31/2026 10:21:26 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/23/2026 10:07:14 AM
- HUTCHMED Initiates Phase III Trial of HMPL-760 in Patients with Relapsed/Refractory Diffuse Large B-cell Lymphoma in China • GlobeNewswire Inc. • 03/23/2026 12:00:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/11/2026 10:08:56 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/09/2026 10:12:01 AM
- HUTCHMED Announces Update on Licensed Oncology Product TAZVERIK® in China • GlobeNewswire Inc. • 03/09/2026 09:30:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/06/2026 11:03:29 AM

